HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Meissner Selected Research

Malaria

11/2021Uptake challenges of intermittent preventive malaria therapy among pregnant women and their health care providers in the Upper West Region of Ghana: A mixed-methods study.
1/2019Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial.
12/2015Safety of insecticide-treated mosquito nets for infants and their mothers: randomized controlled community trial in Burkina Faso.
4/2013Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
6/2010Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
4/2010Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.
2/2009High absolute bioavailability of methylene blue given as an aqueous oral formulation.
4/2008Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.
3/2008Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.
2/2008Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Meissner Research Topics

Disease

11Malaria
11/2021 - 01/2005
6Falciparum Malaria (Plasmodium falciparum Malaria)
01/2019 - 01/2005
3Glucosephosphate Dehydrogenase Deficiency
04/2013 - 01/2005
2Acute Intermittent Porphyria (Porphyria, Acute)
06/2017 - 10/2010
2Hemolysis
04/2013 - 01/2005
1COVID-19
01/2021
1Infections
04/2010

Drug/Important Bio-Agent (IBA)

8Methylene Blue (Methylthioninium Chloride)FDA Link
01/2019 - 01/2005
4Amodiaquine (Camoquin)FDA Link
01/2019 - 02/2008
4Antimalarials (Antimalarial Agents)IBA
04/2013 - 02/2008
3artemisinin (artemisinine)IBA
01/2019 - 02/2008
3Pharmaceutical PreparationsIBA
04/2013 - 01/2005
2ArtesunateIBA
01/2019 - 02/2008
2Chloroquine (Aralen)FDA LinkGeneric
04/2008 - 01/2005
2Drug CombinationsIBA
02/2008 - 01/2005
1pyrimethamine drug combination fanasil (Fansidar)FDA Link
11/2021
1AntibodiesIBA
01/2021
1PrimaquineFDA Link
01/2019
1Heme (Haem)IBA
06/2017
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
06/2017
1Nevirapine (Viramune)FDA Link
10/2010
1Coloring Agents (Dyes)IBA
03/2008
1Biological ProductsIBA
03/2008
1CationsIBA
03/2008
1Proteins (Proteins, Gene)FDA Link
03/2008
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2005

Therapy/Procedure

5Therapeutics
11/2021 - 02/2008
1Insecticide-Treated Bednets
12/2015
1Complementary Therapies (Alternative Medicine)
02/2008